دورية أكاديمية
أعرض في EDS

Development and Validation of the Oxford Skin Cancer Treatment Scale, a Patient-Reported Outcome Measure for Health-Related Quality of Life and Treatment Satisfaction After Skin Cancer Treatment.

التفاصيل البيبلوغرافية
العنوان: Development and Validation of the Oxford Skin Cancer Treatment Scale, a Patient-Reported Outcome Measure for Health-Related Quality of Life and Treatment Satisfaction After Skin Cancer Treatment.
المؤلفون: Kantor J; Department of Dermatology, Center for Clinical Epidemiology and Biostatistics, and Center for Global Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.; Department of Engineering Science & Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom.; Florida Center for Dermatology, St. Augustine, Florida., Aasi SZ; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California., Alam M; Departments of Dermatology.; Otolaryngology.; Medical Social Sciences, Northwestern University, Chicago, Illinois., Paoli J; Region Västra Götaland, Sahlgrenska University Hospital, Department of Dermatology and Venereology, Gothenburg, Sweden., Ratner D; Department of Dermatology, New York University, New York, New York.; Department of Dermatology, NYU Grossman School of Medicine, New York, New York.
المصدر: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.
Publication Model: Ahead of Print
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 9504371 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4725 (Electronic) Linking ISSN: 10760512 NLM ISO Abbreviation: Dermatol Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: 2021- : [Philadelphia] : Wolters Kluwer Health
Original Publication: New York, NY : Elsevier Science, c1995-
مستخلص: Background: Patient-reported outcome measures (PROMs) are necessary to assess the value of skin cancer treatment and to better compare therapeutic options.
Objective: To develop and validate the Oxford Skin Cancer Treatment (OxSCanTr) scale, evaluating health-related quality of life and satisfaction after skin cancer treatment.
Materials and Methods: After qualitative patient interviews, international expert consultation, and item reduction, 2 separate patient samples were used to assess the factor structure of the scale. Exploratory factor analysis with categorical variables and a polychoric correlation matrix followed by promax oblique rotation was performed to establish a factor structure on Group A. Confirmatory factor analysis with a Satorra-Bentler scaled test statistic evaluating the root mean squared error of approximation (RMSEA), standardized root mean squared residual (SRMR), and comparative fit index (CFI) was conducted on Group B. Reliability as internal consistency was assessed using McDonald omega. Convergent and discriminant validity were assessed using the Pearson correlation coefficient.
Results: A total of 480 subjects returned completed surveys (completion rate 96%). A 12-item scale was developed encompassing 4 domains: aesthetic satisfaction, treatment choice satisfaction, treatment experience, and future concerns regarding recurrence/spread. Confirmatory factor analysis showed excellent goodness-of-fit characteristics, with RMSEA = 0.048, SRMR = 0.051, and CFI = 0.962 using the 4-factor model. Reliability was very good (McDonald omega 0.81-0.82), as was convergent validity with the FACE-Q skin cancer module appraisal of scars subscale (r = 0.55). Discriminant validity with a single question regarding being conservative was similarly excellent (r = -0.02).
Conclusion: The OxSCanTr scale is a parsimonious, feasible, and valid PROM for the holistic assessment of the experience of patients who have undergone skin cancer treatment.
(Copyright © 2024 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.)
References: Urban K, Mehrmal S, Uppal P, Giesey RL, et al. The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study. JAAD Int 2021;2:98–108.
Kantor J. Willingness to pay for surgical treatments for basal cell carcinoma: a population-based cross-sectional study. Dermatol Surg 2021;47:467–72.
Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002−2006 and 2007−2011. Am J Prev Med 2015;48:183–7.
Kantor J. Reliability and photographic equivalency of the scar cosmesis assessment and rating (SCAR) scale, an outcome measure for postoperative scars. JAMA Dermatol 2017;153:55–60.
Kantor J. The SCAR (Scar Cosmesis Assessment and Rating) scale: development and validation of a new outcome measure for postoperative scar assessment. Br J Dermatol 2016;175:1394–1396.
Mori S, Lee EH. Beyond the physician's perspective: a review of patient-reported outcomes in dermatologic surgery and cosmetic dermatology. Int J Womens Dermatol 2019;5:21–6.
Lee EH, Klassen AF, Nehal KS, Cano SJ, et al. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population. J Am Acad Dermatol 2013;69:e59–e67.
Joseph AW. Quality of life studies in skin cancer treatment and reconstruction. Facial Plast Surg 2020;36:194–9.
Picco L, Achilla E, Abdin E, Chong SA, et al. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs. BMC Health Serv Res 2016;16:173.
Lee EH, Klassen AF, Cano SJ, Nehal KS, et al. FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery. Br J Dermatol 2018;179:88–94.
Dobbs TD, Gibson JAG, Hughes S, Thind A, et al. Patient-reported outcome measures for soft-tissue facial reconstruction: a systematic review and evaluation of the quality of their measurement properties. Plast Reconstr Surg 2019;143:255–68.
Dobbs TD, Samarendra H, Hughes S, Hutchings HA, et al. Patient-reported outcome measures for facial skin cancer: a systematic review and evaluation of the quality of their measurement properties. Br J Dermatol 2019;180:1018–29.
Gibbons E, Casanas i Comabella C, Fitzpatrick R. A structured review of patient-reported outcome measures for patients with skin cancer, 2013. Br J Dermatol 2013;168:1176–86.
Bates AS, Davis CR, Takwale A, Knepil GJ. Patient-reported outcome measures in nonmelanoma skin cancer of the face: a systematic review. Br J Dermatol 2013;168:1187–94.
Boateng GO, Neilands TB, Frongillo EA, Melgar-Quinonez HR, et al. Best practices for developing and validating scales for health, social, and behavioral research: a primer. Front Public Health 2018;6:149.
Kantor BN, Kantor J. Development and validation of the oxford pandemic attitude scale-COVID-19 (OPAS-C): an internet-based cross-sectional study in the UK and USA. BMJ Open 2021;11:e043758.
Watkins MW. A Step-by-step Guide to Exploratory Factor Analysis with Stata. New York, NY: Routledge; 2022.
Kantor J, Vanderslott S, Morrison M, Pollard AJ, et al. The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public. BMJ Open 2023;13:e074466.
Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res 2018;27:1159–70.
Lorenzo-Seva U, Ferrando PJ. MSA: the Forgotten Index for identifying inappropriate items before computing exploratory item factor analysis. Methodology 2021;17:296–306.
Dinno A. Implementing Horn's parallel analysis for principal component analysis and factor analysis. Stata J 2009;9:291–8.
Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika 1965;30:179–85.
Garrido LE, Abad FJ, Ponsoda V. Performance of velicer's minimum average partial factor retention method with categorical variables. Educ Psychol Meas 2011;71:551–70.
Ledesma RD, Valero-Mora P, Macbeth G. The screen test and the number of factors: a dynamic graphics approach. Span J Psychol 2015;18:E11.
Cappelleri JC, Jason Lundy J, Hays RD. Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures. Clin Ther 2014;36:648–62.
Holgado-Tello FP, Chacón-Moscoso S, Barbero-García I, Vila-Abad E. Polychoric versus Pearson correlations in exploratory and confirmatory factor analysis of ordinal variables. Qual Quant 2010;44:153–66.
Flora DB, Curran PJ. An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods 2004;9:466–91.
Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess 2003;80:99–103.
Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociol Methods Res 1992;21:230–58.
Lee EB, Ford A, Clarey D, Wysong A, et al. Patient outcomes and satisfaction after Mohs micrographic surgery in patients with nonmelanoma skin cancer. Dermatol Surg 2021;47:1190–4.
Klassen AF, Cano SJ, Schwitzer JA, Scott AM, et al. FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg 2015;135:375–86.
Rencz F, Gergely LH, Wikonkál N, Gáspár K, et al. Dermatology Life Quality Index (DLQI) score bands are applicable to DLQI‐Relevant (DLQI‐R) scoring. J Eur Acad Dermatol Venereol 2020;34:e484–e486.
Mundy LR, Miller HC, Klassen AF, Cano SJ, et al. Patient-reported outcome instruments for surgical and traumatic scars: a systematic review of their development, content, and psychometric validation. Aesthetic Plast Surg 2016;40:792–800.
Wang AWT, Chang SM, Chang CS, Chen ST, et al. Regret about surgical decisions among early‐stage breast cancer patients: effects of the congruence between patients' preferred and actual decision‐making roles. Psychooncology 2018;27:508–14.
Catalan-Griffiths A, Pasquali P, Arias-Santiago S, Valeron P, et al. Shared decision making quality and decisional regret in patients with low-risk superficial basal cell carcinoma: a prospective, multicenter cohort study. JAAD Int 2023;13:159–63.
Bath‐Hextall F, Nalubega S, Evans C. The needs and experiences of patients with skin cancer: a qualitative systematic review with metasynthesis. Br J Dermatol 2017;177:666–87.
Renna ME, Rosie Shrout M, Madison AA, Lustberg M, et al. Worry and rumination in breast cancer patients: perseveration worsens self-rated health. J Behav Med 2021;44:253–9.
Lukowiak TM, Perz AM, Veerabagu SA, Lee MP, et al. Patient quality of life after interpolated flap repair of nasal Mohs surgery defects: a multicenter prospective cohort study. JAMA Dermatol 2021;157:1213–6.
تواريخ الأحداث: Date Created: 20240712 Latest Revision: 20240712
رمز التحديث: 20240713
DOI: 10.1097/DSS.0000000000004305
PMID: 38996368
قاعدة البيانات: MEDLINE
الوصف
تدمد:1524-4725
DOI:10.1097/DSS.0000000000004305